New black 1536 well cycloolefin microplateGreiner Bio-One, a leading technology partner for the diagnostic and pharmaceutical industry, will be showcasing a new black 1536 well cycloolefin microplate at Analytica 2012. This microplate was developed specifically for use in highly automated systems.
With the launch of a cycloolefin solid bottom black 1536 well microplate for fluorescence measurements and light protected compound storage Greiner Bio-One is once again setting the standard in the field of highly automated drug discovery. The new microplate combines the excellent optical properties of cycloolefins with the company’s know-how in the development and production of high-quality microplates.
Due to their quartz glass-like properties and as a result of their particularly low autofluorescence in the lower UV range, cycloolefins are perfect for sensitive fluorescence measurements. Thanks to their low water vapour permeability and their resistance to polar solvents such as dimethyl sulfoxide, cycloolefin microplates are as well suitable for sample storage in high-throughput screening.
The new black 1536 well cycloolefin microplate was developed specifically for the use in highly automated systems. It has no alphanumerical coding and is ideal for automated sealing techniques using metal cover plates such as those used in the ultra-high throughput screening system (uHTS) of automation supplier GNF Systems.
Greiner Bio-One at Analytica, 17 - 20 April 2012, Neue Messe Munich, Stand A3.241/340
Greiner Bio-One GmbH – BioScience Division
Greiner Bio-One is specialised in the development, production and distribution of plastic laboratory products. The company is a technology partner for universities, research institutes and the diagnostic, pharmaceutical and biotechnology industries as well. With the BioScience division, Greiner Bio-One ranks among the leading providers of specialised products for the cultivation and analysis of cell and tissue cultures, as well as microplates for high-throughput screening, allowing industry and research most rapid and efficient drug screening. Additionally Greiner Bio-One develops innovative biochip technologies for genotyping.
Under the management of Georg Heftberger, Rainer Perneker and Heinz Schmid, the German headquarters of the BioScience division in Frickenhausen (Baden-Württemberg) controls the whole research and development activities in the product ranges Cell Culture, High-Throughput Screening, Biochips and OEM.
Greiner Bio-One GmbH is a division of Greiner Bio-One International AG, based in Kremsmuenster (Austria). Today Greiner Bio-One International AG generates a turnover of 327 million euros. It has over 1,700 employees and operates globally with 20 subsidiaries and numerous distributors in more than 100 countries.
Further information about Greiner Bio-One can be obtained from:
Greiner Bio-One GmbH
|Zeeb Kommunikation GmbH|
Hohenheimer Straße 58a
Phone: (07 11) 60707-19
Fax: (07 11) 60707-39